Skip to main content
logo
Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
1.190
-0.100 (-7.75%)
At close: Jan 2, 2026, 4:00 PM EST
1.180
-0.010 (-0.84%)
Pre-market: Jan 5, 2026, 4:09 AM EST

Pasithea Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
----0.02-
Cost of Revenue
----0.02-
Gross Profit
-----0-
Selling, General & Admin
7.127.057.889.924.510.06
Research & Development
6.757.28.12.67--
Operating Expenses
13.8614.2515.9812.594.510.06
Operating Income
-13.86-14.25-15.98-12.59-4.51-0.06
Interest Expense
-----0-
Interest & Investment Income
0.230.420.42---
Other Non Operating Income (Expenses)
0.14-0.080.061.852.33-
EBT Excluding Unusual Items
-13.5-13.9-15.51-10.74-2.17-0.06
Legal Settlements
----1--
Other Unusual Items
---0.01--
Pretax Income
-13.49-13.9-15.51-11.73-2.17-0.06
Earnings From Continuing Operations
-13.49-13.9-15.51-11.73-2.17-0.06
Earnings From Discontinued Operations
---0.45-2.21--
Net Income
-13.49-13.9-15.96-13.94-2.17-0.06
Net Income to Common
-13.49-13.9-15.96-13.94-2.17-0.06
Shares Outstanding (Basic)
411110
Shares Outstanding (Diluted)
411110
Shares Change (YoY)
298.39%-10.64%-2.83%142.65%41.29%-
EPS (Basic)
-3.25-12.69-13.01-11.04-4.18-
EPS (Diluted)
-3.25-12.69-13.01-11.04-4.18-
Free Cash Flow
-12.26-13.92-13.46-13.8-3.2-0.06
Free Cash Flow Per Share
-2.95-12.70-10.97-10.93-6.14-0.16
Gross Margin
-----14.69%-
Operating Margin
-----29925.73%-
Profit Margin
-----14430.49%-
Free Cash Flow Margin
-----21216.05%-
EBITDA
-13.19-13.6-15.33-12.58-4.51-
D&A For EBITDA
0.670.650.650.010-
EBIT
-13.86-14.25-15.98-12.59-4.51-0.06
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q